Abstract
A one-stage macroscopic test for platelet agglutination was used to study the effect of thrombin and thrombin-cation mixtures on washed platelets. Conclusions regarding platelet agglutination are as follows: (a) Canine, bovine, or human thrombin alone does not cause agglutination of canine or human platelets. (b) Thrombin with calcium or magnesium causes rapid platelet agglutination. Both calcium and magnesium are active at physiologic concentrations. Divalent manganese or cadmium ions can be substituted for calcium or magnesium. (c) The agglutination reaction is affected but little by the species of origin of thrombin or platelets, or by variations in ionic strength or pH over a broad range. (d) Temperature at which the reaction is carried out is critical; optimal temperature for the test is 28°C. (e) Agglutination is inhibited by high ionic strength, by pH values outside the range 6.4–8.6, and by temperatures outside the range 25–28°C. High concentrations of calcium have a specific inhibitory effect. (f) Platelet agglutination time is as sensitive an index of thrombin concentration as is the fibrinogen clotting time. A comparison is made between divalent cations which influence platelet agglutination induced by thrombin, TAg', and TAg. A similar comparison is made of cations influencing the action of thrombin on the "substrates," fibrinogen, TAMe, and platelets.
Full Text
The Full Text of this article is available as a PDF (831.0 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ALEXANDER B., GOLDSTEIN R., RICH L., LE BOLLOC'H A. G., DIAMOND L. K., BORGES W. Congenital afibrinogenemia; a study of some basic aspects of coagulation. Blood. 1954 Sep;9(9):843–865. [PubMed] [Google Scholar]
- BERGSAGEL D. E. Viscous metamorphosis of platelets; morphological platelet changes induced by an intermediate product of blood thromboplastin formation. Br J Haematol. 1956 Apr;2(2):130–138. doi: 10.1111/j.1365-2141.1956.tb06821.x. [DOI] [PubMed] [Google Scholar]
- BOUNAMEAUX Y. Thrombine et agglutination plaquettaire. Arch Int Physiol Biochim. 1955 Jun;63(2):243–245. doi: 10.3109/13813455509150414. [DOI] [PubMed] [Google Scholar]
- BRINKHOUS K. M., LEROY E. C., CORNELL W. P., BROWN R. C., HAZLEHURST J. L., VENNART G. P. Macroscopic studies of platelet agglutination; nature of thrombocyte agglutinating activity of plasma. Proc Soc Exp Biol Med. 1958 Jun;98(2):379–383. doi: 10.3181/00379727-98-24050. [DOI] [PubMed] [Google Scholar]
- DESFORGES J. F., BIGELOW F. S. An action of thrombin on platelets in accelerating clotting. Blood. 1954 Feb;9(2):153–162. [PubMed] [Google Scholar]
- Greville G. D., Lehmann H. Cation antagonism in blood coagulation. J Physiol. 1944 Sep 29;103(2):175–184. doi: 10.1113/jphysiol.1944.sp004070. [DOI] [PMC free article] [PubMed] [Google Scholar]
- HJORT P., RAPAPORT S. I., OWREN P. A. Evidence that platelet accelerator (platelet factor 1) is adsorbed plasma proaccelerin. Blood. 1955 Nov;10(11):1139–1150. [PubMed] [Google Scholar]
- LEROY E. C., MASON R. G., BRINKHOUS K. M. Species differences in platelet agglutination in man and in the dog, swine and rabbit. Am J Physiol. 1960 Jul;199:183–186. doi: 10.1152/ajplegacy.1960.199.1.183. [DOI] [PubMed] [Google Scholar]
- MASON R. G., LEROY E. C., BRINKHOUS K. M. Cation specificity of thrombocyte agglutinating activity (TAg) of canine plasma. Proc Soc Exp Biol Med. 1959 Oct;102:253–255. doi: 10.3181/00379727-102-25210. [DOI] [PubMed] [Google Scholar]
- RASMUSSEN P. S. Purification of thrombin by chromatography. Biochim Biophys Acta. 1955 Jan;16(1):157–158. doi: 10.1016/0006-3002(55)90194-3. [DOI] [PubMed] [Google Scholar]
- RATNOFF O. D., POTTS A. M. The accelerating effect of calcium and other cations on the conversion of fibrinogen to fibrin. J Clin Invest. 1954 Feb;33(2):206–210. doi: 10.1172/JCI102886. [DOI] [PMC free article] [PubMed] [Google Scholar]
- RONWIN E. Thrombin properties. Can J Biochem Physiol. 1957 Sep;35(9):743–758. [PubMed] [Google Scholar]
- SEEGERS W. H. Activation of purified prothrombin. Proc Soc Exp Biol Med. 1949 Dec;72(3):677–680. doi: 10.3181/00379727-72-17540. [DOI] [PubMed] [Google Scholar]
- SELIGMANN M., GOUDEMAND B., JANIN A., BERNARD J., GRABAR P. Etude immunochimiques sur la présence de fibrinogène dans des extraits de plaquettes humaines lavées et dans certains extraits leucocytaires. Rev Hematol. 1957 Jul-Aug;12(3):302–327. [PubMed] [Google Scholar]
- SENTA S. S., ROSENTHAL R. L. Intermediate stages in platelet alterations during coagulation. Acta Haematol. 1958 Apr-May;19(4-5):209–221. doi: 10.1159/000205436. [DOI] [PubMed] [Google Scholar]
- SILBER R., BENITEZ R., EVELAND W. C., AKEROYD J. H., DUNNE C. J. The application of fluorescent antibody methods to the study of platelets. Blood. 1960 Jul;16:958–967. [PubMed] [Google Scholar]
- STEFANINI M. Autocatalytic formation of thrombin in blood coagulation. Acta Med Scand. 1951;140(4):290–306. doi: 10.1111/j.0954-6820.1951.tb10180.x. [DOI] [PubMed] [Google Scholar]
- STEFANINI M., SILVERBERG J. H. Studies on platelets. I. The relationship of platelet agglutination to the mechanism of blood coagulation. Am J Clin Pathol. 1951 Nov;21(11):1030–1038. doi: 10.1093/ajcp/21.11.1030. [DOI] [PubMed] [Google Scholar]
- Smith H. P., Warner E. D., Brinkhous K. M. PROTHROMBIN DEFICIENCY AND THE BLEEDING TENDENCY IN LIVER INJURY (CHLOROFORM INTOXICATION). J Exp Med. 1937 Nov 30;66(6):801–811. doi: 10.1084/jem.66.6.801. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wright J. H., Minot G. R. THE VISCOUS METAMORPHOSIS OF THE BLOOD PLATELETS. J Exp Med. 1917 Sep 1;26(3):395–409. doi: 10.1084/jem.26.3.395. [DOI] [PMC free article] [PubMed] [Google Scholar]